CEACAM5 and rectal cancer: Despite these limitations, a major strength of this study lies in its comprehensive evaluation of both static and dynamic changes in inflammatory (NLR, PLR) and tumor (CEA) markers before and after neoadjuvant chemoradiotherapy in a well-defined cohort of patients with locally advanced rectal cancer and standardized management protocol.